We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3weeks
Sample Provided: yes
Payment Terms: T/T
Antimicrobial peptides (AMPs) have become drug candidates for the treatment of gram-negative bacterial infections, endotoxin shock and sepsis, because these peptides not only have the treatment of bacterial infections, endotoxin shock and sepsis, but also have broad-spectrum antibacterial Activity, in addition, it has antibacterial ability, and can bind endotoxin, and then block the release of cytokines stimulated by endotoxin, thus having a therapeutic effect. LL-37 is the only human-derived antimicrobial peptide in the cathelicidin family. There are many studies on LL-37. LL-37 RKS is a sequence of LL-37, which contains 31 amino acids. The molecular structure is relatively small and has better Cell penetration selectivity.LL-37 RKS contains the main functional fragments in antimicrobial peptides. Although the sequences are different, they have similar biological functions. The difference is that the half-life in the organism is different.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
